Views & Analysis Bad behaviour: why understanding human behaviour can improve... Why did I do that? A common question I often ask myself after opening the biscuit packet for the third time in an hour.
Views & Analysis Behaviour science: the new capability every pharma company s... Mark Lightowler takes a look at why medical interventions are evolving beyond drugs to also help patients change behaviours that impact their disease.
Views & Analysis How behavioural science is helping in the fight against COVI... Thanks to COVID-19, just about every form of media we consume right now is focused on aspects of changing how we live.
News Akebia joins GSK in US market for oral CKD anaemia drugs The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS
Digital Sponsored Innovation as Strategy: Enabling life sciences of the future Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.